BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Prognosis
2169 results:

  • 1. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Tian Q; Huang J; Zhang Q; Zhao J
    Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced cervical Squamous Cell Carcinoma.
    Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
    Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
    BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [
    Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
    BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]    [Full Text] [Related]  

  • 6. Sarcoma of the uterine cervix: experience of a single center.
    Yuan H; Li L; Li N; Yao H
    World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
    Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
    Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    Zhang Y; Li L; Han Q; Wen L
    J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Construction of artificial neural network (ANN) based on predictive value of prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) in patients with cervical squamous cell carcinoma.
    Li X; Ou C; He A
    Medicine (Baltimore); 2024 Apr; 103(14):e37680. PubMed ID: 38579053
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Zeng S; Yang P; Xiao S; Liu L
    Sci Rep; 2024 Apr; 14(1):7681. PubMed ID: 38561337
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. High P16INK4A Expression, Keratinizing Features, and Surgical Margin-Free Status are Associated with Improved Survival in Patients with Oral Squamous Cell Carcinomas.
    Anwar SL; Dwianingsih EK; Lestari SP; Sugandhi W; Cahyono R; Pradana GD
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):857-865. PubMed ID: 38546068
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
    Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
    Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
    Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
    Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical implication of neck dissection for metastatic lymph nodes originating from non-head and neck regions.
    Kim MJ; Kang SH; Kwon M; Jung YH; Choi SH; Nam SY; Lee YS
    Acta Otolaryngol; 2024 Feb; 144(2):153-157. PubMed ID: 38491920
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
    Olaleye OO; Kim DH; Spriggs KA
    BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Retrospective Analysis of All Types of Adjuvant Radiotherapy in Endometrial cancer: Single-Center Experiences in a Middle-Income Country.
    Chitapanarux N; Tharavichitkul E; Kittidachanan K; Muangwong P; Chakrabandhu S; Klunklin P; Onchan W; Jia-Mahasap B; Torapichattrakul P; Chitapanarux I
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):485-494. PubMed ID: 38415534
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with cervical cancer: A Model-Based Period Analysis.
    Fan X; He W; Zhang Q; Zhang B; Dong L; Li L; Liu X
    Cancer Control; 2024; 31():10732748241232324. PubMed ID: 38408865
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Incidence, prognostic factors, and a nomogram of cervical cancer with lung metastasis: A SEER-based study.
    Shan Y; Ding Z; Chen A; Cui Z
    J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102757. PubMed ID: 38403266
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
    Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study.
    Peng C; Li X; Tang W; Zhu W; Yan P; Chen J; Zhang X; Guo Q; Wu Q; Wang Q; Liu N; Ma A; Lu Y; Lv P; Liu J; Xie P
    Int Immunopharmacol; 2024 Mar; 129():111578. PubMed ID: 38330795
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 109.